Watch for Interactions Between Amiodarone and Hep C Meds

June 2015

You'll hear reports of a potentially dangerous interaction between amiodarone and the new hep C drug, sofosbuvir (Sovaldi, Harvoni).

Combining amiodarone with sofosbuvir-containing hep C regimens may lead to serious bradycardia, cardiac arrest, and pacemaker placement.

Patients seem to be at higher risk for bradycardia if they are also on a beta-blocker or have cardiovascular or liver disease.

Get concise advice on drug therapy, plus unlimited access to CE

Pharmacist's Letter membership benefits include:

12 issues every year — what you need to know and do, right now
Quick, practical reference charts and tools
Comprehensive CE library to meet license renewal and state requirements
Multiple course formats including live webinars, podcasts, and CE-in-the-Letter to match your learning style
Plus much more!

Choose the right tier for your needs today.

Already a subscriber? Log in

Volume pricing available. Get a quote